N-甲基-2-(4''-N-乙基咔唑基)-[60]富勒烯吡咯烷及其衍生物的合成, 电荷分离态特征

通过1,3-偶极环加成方法在微波照射下合成了N-甲基-2-(4'-N-乙基咔唑基)-富勒烯吡咯烷(C₆₀-Cz)和N-甲基-2- (4'-N,N-二苯基氨基)-富勒烯吡咯烷(C₆₀-TPA), 用质谱, ¹H NMR, IR等对其结构进行了表征. 用激光光解时间分辨瞬态谱研究了N-甲基-2-(4'-N-乙基咔唑基)-富勒烯吡咯烷的分子内电荷转移过程, 在近红外区观测到了长寿命电荷分离态C₆₀^•--C_Z^•+的存在, 其寿命为0.28 μs. 运用Gaussian 98量子化学程序包, 利用密度泛函的方法对N-甲基-2-(4'-N,N-二苯基氨基)-富勒烯吡咯烷几何构型进行了优化, 并在优化基础上用ZINDO方法计算了化合物C₆₀-TPA的电子光谱, 计算结果表明, 光谱吸收峰在440 nm, 与实验值433 nm基本一致.     

N-甲基-2-(4'-N-乙基咔唑基)-[60]富勒烯吡咯烷及其衍生物的合成, 电荷分离态特征

通过1,3-偶极环加成方法在微波照射下合成了N-甲基-2-(4'-N-乙基咔唑基)-富勒烯吡咯烷(C₆₀-Cz)和N-甲基-2- (4'-N,N-二苯基氨基)-富勒烯吡咯烷(C₆₀-TPA), 用质谱, ¹H NMR, IR等对其结构进行了表征. 用激光光解时间分辨瞬态谱研究了N-甲基-2-(4'-N-乙基咔唑基)-富勒烯吡咯烷的分子内电荷转移过程, 在近红外区观测到了长寿命电荷分离态C₆₀^•--C_Z^•+的存在, 其寿命为0.28 μs. 运用Gaussian 98量子化学程序包, 利用密度泛函的方法对N-甲基-2-(4'-N,N-二苯基氨基)-富勒烯吡咯烷几何构型进行了优化, 并在优化基础上用ZINDO方法计算了化合物C₆₀-TPA的电子光谱, 计算结果表明, 光谱吸收峰在440 nm, 与实验值433 nm基本一致.     

二{2-{2-{9-乙基-6-[2-(8-羟基喹啉-2-基)乙烯基]咔唑-3-基}乙烯}-8-羟基喹啉}锌配合物的合成与荧光光谱特性

合成了新的N-乙基咔唑衍生物: 3,6-二[2-(8-羟基喹啉基)乙烯基]咔唑(4)及其锌配合物(5); 化合物4经质谱、红外光谱、核磁共振氢谱、元素分析表征其结构, 并测定了它的荧光光谱. 结果显示: 化合物4的荧光发射为蓝绿色光(500 nm), 其发射光谱随着溶剂极性的增大荧光光谱向长波方向移动(即发生红移); 同时, 考察了化合物5的荧光性质, 其荧光发光峰值为600 nm, 与2-甲基-8-羟基喹啉锌相比, 发生了明显的红移.     

N-甲基-2-(β-羟乙基)吡咯烷的合成方法研究

分别用吡咯烷酮和N-甲基吡咯烷酮为原料,经侧链化、还原水解和N-甲基化反应合成了抗过敏新药氯马斯丁的关键中间体N-甲基-2-(β-羟乙基)吡咯烷,获得了较高的总收率.     

含有联苯咔唑的富勒烯C60/C70衍生物的合成、 电化学性质和双光子吸收研究

富勒烯C60/C70与肌氨酸和联苯咔唑醛的1,3-偶极环加成反应, 获得了富勒烯C60/C70-联苯咔唑衍生物3和4, 用1H NMR, 13C NMR, MALDI-TOF-MS表征其结构; 研究了化合物3和4的紫外、荧光和电化学性质; 利用激光光解、Z扫描方法研究其双光子吸收特性.     

9-戊基咔唑-3,6-双-(炔苯基-4-甲酸乙酯)的合成与双光子特性研究

采用钯催化的碳碳偶合反应合成了9-戊基咔唑-3,6-双-(炔苯基-4-甲酸乙酯)(I).进一步研究了化合物I在四氢呋喃和40%四氢呋喃水溶液中的光物理性质,结果显示,化合物I在40%四氢呋喃水溶液中的紫外吸收峰位置与其四氢呋喃溶液相比没有发生明显移动,它在40%四氢呋喃水溶液中的单光子荧光发射峰出现在453 nm,较其在四氢呋喃溶液的发射有42 nm红移,其荧光量子效率为0.44.用波长为660 nm飞秒激光激发时,化合物I在40%四氢呋喃水溶液中的双光子荧光发射最大峰红移至489 nm,其双光子吸收截面值为251GM,比其在四氢呋喃溶液中的截面(151 GM)增强了60%.     

61-甲基-61-[12-(N,N-四氯邻苯二甲酰基)脱氢枞胺]-1,2-亚甲基富勒烯[60]的合成

以脱氢枞胺为原料,经氨基酰化、12位乙酰化、与对甲苯磺酰肼形成对甲苯磺酰腙衍生物,再通过卡宾中间体与C60进行[2+1]环加成反应合成了C60-脱氢枞胺衍生物。目标化合物经IR,UV-Vis,1H NMR,13C NMR,MALDI-TOF MS表征,所得化合物为[6,6]闭环结构C60加成产物。     

[Cu(en)_2]V_6O_(14)晶体的水热合成、晶体结构和电化学性质

通过水热方法合成了一种三维无机-有机多金属钒酸盐[Cu(en)_2]V_6O_(14),并测定了其晶体结构.该化合物经过X-射线单晶衍射、元素分析、红外光谱表征和热失重分析,并研究了它的电化学性质.     

6-溴-3-[2-(6-溴-2-甲氧基喹啉-3-基)-1,2-二苯乙基]-2-甲氧基喹啉的合成

以6-溴-3-(氯苯基甲基)-2-甲氧基喹啉(2)为起始原料,经过偶合对接反应合成了新型喹啉类抗结核药物TMC-207的衍生物6-溴-3-[2-(6-溴-2-甲氧基喹啉-3-基)-1,2-二苯乙基]-2-甲氧基喹啉,其结构经1H NMR和HR-MS确证.最佳反应条件:2 10 mmol,Et_3N 5 mL,KI 0.17 g,乙腈150 mL,于80 ℃反应6 h,收率73%.     

2′,5′-二氢-1′H-吡咯骈[3′,4′:1,2]][60]富勒烯衍生物的合成

以甘氨酸乙酯盐酸盐与取代的苯甲醛为原料,制得了一系列亚胺,然后用亚胺与C(60)反应,得到带有不同取代基的吡咯烷骈[60]富勒烯衍生物.经~1H NMR,~(13)C NMR,FT-IR,UV-vis以及TOF-SIMS等方法对所得化合物结构进行了表征,并进行了产物的生物活性测试.     

Synthesis and Crystal Structure of {4-[2-（9- Hexyl-9H-carbazol-3-yl）vinyl]phenyl} Dimethylamine

The title compound {4-[2-(9-hexyl-9H-carbazol-3-yl)vinyl]phenyl} dimethylamine has been synthesized by the well known Wittig reaction, and its crystal structure was determined by single-crystal X-ray diffraction analysis. It crystallizes in monoclinic, space group P21/c with a = 47.87(2), b = 10.222(4), c = 9.612(4) , β = 92.401(9)o, V = 4699(3) 3, Z = 8, C28H32N2, Mr = 396.56, Dc = 1.121 g/cm3, F(000) = 1712 and μ(MoKa) = 0.065 mm-1. The final R and wR are 0.0793 and 0.1983, respectively for 3524 observed reflections with I > 2σ(I). In the title compound, the bond lengths are normal, and the crystal is stabilized by Van der Waals’ forces.     

3-{2-([5,6]-咪唑-1,10-邻菲咯啉)]}-3′-甲酸-2,2’-联吡啶的合成和晶体结构

以1,10-邻菲咯啉为原料,经三步反应生成了标题化合物,化合物经1H NMR,MS和X-射线单晶衍射表征.结果表明,化合物晶体为单斜晶系,空间群,P21/c,a=1.24828(16)nm,b=1.18534(15)nm,c=1.37542(16)nm,α=90.00°,β=109.268(4)°,γ=90.00°,V=1.9211(4)nm3,Z=4,Mr=418.41,Dc=1.440g.cm-3,μ=0.097mm-1,F(000)=856,R1=0.0633,wR2=0.1803.CCDC:728109.     

Synthesis, Crystal Structure and Electrochemical Properties of [Ni(phen)_3]·(m-nitrobenzoic acid)_2·(H_2O)

A new nickel(II) coordination complex [Ni(phen)3]·(m-nitrobenzoic acid)2·(H2O) was synthesized by self-assembly of m-nitrobenzoic acid, 1,10-phenanthroline and nickelous per- chlorate. It crystallizes in the monoclinic system, space group C2/c, with a = 2.4596(6), b = 1.2124(3), c = 1.9824(5) nm, β = 97.088(5)o, V = 5.866(3) nm3, Dc = 1.474 g/cm3, Z = 4, Mr = 1301.82, μ(MoKα) = 0.417 mm-1 F(000) = 2688, R = 0.0493 and wR = 0.1025. Structural deter- mination indicates that the nickel(II) ion is coordinated with six nitrogen atoms from three phens, giving a distorted octahedral coordination geometry. The cyclic voltametric analysis shows that the electron transfer in the electrode reaction is irreversible.     

(E)-N-芳基-3-[2-(8-羟基喹啉基)-乙烯基]咔唑的合成、抗氧化活性及促进鼠骨髓间质干细胞增殖的研究

设计合成了3-[2-(8-羟基喹啉基)-乙烯基]-N-对甲苯基咔唑(8)和3-[2-(8-羟基喹啉基)-乙烯基]-N-对甲氧苯基咔唑(9)两个新的化合物, 用IR, MS, 1H NMR和元素分析确认其结构. 并利用DPPH•方法, 超氧阴离子自由基( )法, 羟基自由基HO•法和噻唑蓝比色法(MTT法)分别测定了目标产物的抗氧化活性和调控鼠骨髓间质干细胞(MSCs)的作用. 结果表明, 这两种化合物对DPPH•自由基、超氧阴离子自由基和羟基自由基具有较强的抗氧化活性, 化合物9在低浓度时对鼠骨髓间质干细胞增殖有很好的促进作用.     

Synthesis, Crystal Structure and Electrochemical Properties of Complex[Ni(2,2''-bipy)2(ClC6H4COO)(H2O)](ClO4)

A new nickel(Ⅱ) coordination complex [Ni(2,2'-bipy)2(ClC6H4COO)(H2O)](ClO4) was synthesized by self-assembly reaction of m-chlorobenzoic acid, 2,2'-bipy and Ni(ClO4)2(6H2O. The crystal of the title compound belongs to monoclinic system, space group P21/n with a = 0.77764(14), b = 2.6572(5), c = 1.3637(2) nm, β = 96.456(3)°, V = 2.8000(9) nm3, Dc = 1.528 g/cm3, Z = 4, Mr = 644.10, μ(MoKα) = 0.937 mm-1, F(000) =1320, R = 0.0549 and wR = 0.1164. Structure analysis shows that the nickel(Ⅱ) ion is coordinated with four nitrogen atoms from two bipys as well as two oxygen atoms from m-chlorobenzoic acid and water, respectively, giving a distorted octahedral coordination geometry. The cyclic voltametric behavior of the complex is also presented.     

2-(N'-乙基咔唑-3'-烯基)-8-羟基喹啉的合成及理论研究

设计合成了2-(N'-乙基咔唑-3'-烯基)-8-羟基喹啉. 以UV-Vis, ¹H NMR, FT-IR, 元素分析和MS进行了结构表征, 并测定了产物的光致发光(PL)性质. 运用Gaussian98量子化学程序包, 采用B3LYP密度泛函(DFT)的方法, 在6-31G(d,p)水平上对分子的几何构型进行结构优化; 预测目标产物的振动光谱, 结果表明与实验值相符.     

Alternative Synthesis of 5-(1H-Pyrazol-4-yl)-2-{6-[(2,2,6,6-tetramethylpiperidin-4-yl)oxy]pyridazin-3-yl}phenol

A scalable and environmentally benign route to the free base of branaplam, a small molecule splicing modulator, was identified and developed. This alternative approach circumvented the inherent risk of dioxin formation associated with ortho-halo phenol derivatives present in the previous route. A Friedel–Crafts approach provided a reliable access to the key intermediate, subsequently followed by a Suzuki–Miyaura cross-coupling. Multiple process aspects of the synthetic approach were evaluated, and a robust process for its large-scale synthesis was developed and successfully demonstrated.     

Solvent-free microwave assisted synthesis of substituted (E)-phenyl{3-(2-[1-phenyl-3-(thiophen-2-yl)-1H-pyrazol-4-yl]vinyl)benzofuran-2-yl}methanones and their antimicrobial activity

Russian Journal of General Chemistry - New substituted (E)-phenyl{3-(2-[1-phenyl-3-(thiophen-2-yl)-1H-pyrazol-4-yl]vinyl)benzofuran-2-yl}methanones have been synthesized from substituted...